The effect on total mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: a real practice analysis in Italy
M Di Martino, N Agabiti, S Cascini… - COPD: Journal of …, 2016 - Taylor & Francis
Purpose. Chronic therapy with long-acting bronchodilators (LB) is recommended to treat
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy.
M Di Martino, N Agabiti, S Cascini, U Kirchmayer… - COPD, 2015 - europepmc.org
Purpose Chronic therapy with long-acting bronchodilators (LB) is recommended to treat
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
The Effect on Total Mortality of Adding Inhaled Corticosteroids to Long-Acting Bronchodilators for COPD: A Real Practice Analysis in Italy
M Di Martino, N Agabiti, S Cascini, U Kirchmayer… - COPD, 2016 - pubmed.ncbi.nlm.nih.gov
Purpose Chronic therapy with long-acting bronchodilators (LB) is recommended to treat
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …
moderate-to-severe COPD. Although the benefits of adding inhaled corticosteroid (ICS) to …